Efficacy and Safety of BBT-401-1S in Ulcerative Colitis
Status:
Terminated
Trial end date:
2020-07-31
Target enrollment:
Participant gender:
Summary
This is randomized, placebo-controlled, dose-escalation, multicenter, Phase 2 study to
evaluate the efficacy and safety of BBT-401-1S in patients with active ulcerative colitis.
This study consists of three cohorts with 16-week treatment period per cohort that will be
conducted sequentially.